{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:52:12Z","timestamp":1788364332714,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","award":["HRZZ-IP-2020-02-9162"],"award-info":[{"award-number":["HRZZ-IP-2020-02-9162"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["No. 09-I02-03-V01-00021"],"award-info":[{"award-number":["No. 09-I02-03-V01-00021"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010783","name":"Slovensk\u00e1 Akad\u00e9mia Vied","doi-asserted-by":"publisher","award":["SAS-NSTC-JRP-2024-03_SUPRA-SIGHT"],"award-info":[{"award-number":["SAS-NSTC-JRP-2024-03_SUPRA-SIGHT"]}],"id":[{"id":"10.13039\/100010783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["2\/0034\/22"],"award-info":[{"award-number":["2\/0034\/22"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation programme","award":["No.101007642; PhytoApp"],"award-info":[{"award-number":["No.101007642; PhytoApp"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23467-0","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:20:57Z","timestamp":1763076057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the structure\u2013activity relationships of organometallic ferrocene-pyrazole and ferrocene-pyrimidine curcumin analogues in amyloid-\u03b2 aggregation and glioblastoma treatment"],"prefix":"10.1038","volume":"15","author":[{"given":"Veronika","family":"Kova\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Huntosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikitas","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Zong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Ching","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shean-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Dolenec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Siposova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"4","key":"23467_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/acel.12601","volume":"16","author":"SS Khan","year":"2017","unstructured":"Khan, S. S., Singer, B. D. & Vaughan, D. E. Molecular and physiological manifestations and measurement of aging in humans. Aging Cell. 16 (4), 624\u2013633 (2017).","journal-title":"Aging Cell."},{"issue":"2","key":"23467_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols, E., Steinmetz, J. D. & Vollset, S. E. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public. Health. 7 (2), 105\u2013125 (2022).","journal-title":"Lancet Public. Health"},{"key":"23467_CR3","unstructured":"Selkoe, D. J. & Lansbury, P. J. Alzheimer\u2019s Disease Is the Most Common Neurodegenerative Disorder. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th Ed. (Lippincott-Raven, 1999)."},{"key":"23467_CR4","volume-title":"Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities","author":"G Hake","year":"2023","unstructured":"Hake, G., Mhaske, A. & Shukla, R. Drug delivery strategies in Alzheimer\u2019s disease. In Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities. (Eds. Mishra, A. & Kulhari, H.) (Springer, 2023)."},{"key":"23467_CR5","unstructured":"Long, S., Benoist, C. & Weidner, W. World Alzheimer Report 2023: Reducing Dementia Risk: Never Too early, Never Too Late (Alzheimer\u2019s Disease International, 2023)."},{"key":"23467_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi, R. E. & Bertram, L. Twenty years of the alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell 120, 545\u2013555 (2005).","journal-title":"Cell"},{"issue":"4","key":"23467_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71 (4), 505\u2013508 (2014).","journal-title":"JAMA Neurol."},{"key":"23467_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fnagi.2020.00265","volume":"12","author":"P d\u2019Errico","year":"2020","unstructured":"d\u2019Errico, P. & Meyer-Luehmann, M. Mechanisms of pathogenic Tau and A\u03b2 protein spreading in Alzheimer\u2019s disease. Front. Aging Neurosci. 12, 265 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"23467_CR9","first-page":"2181","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Interaction between A\u03b2 and Tau in the pathogenesis of Alzheimer\u2019s disease. J. Biol. Sci. 17, 2181\u20132192 (2021).","journal-title":"J. Biol. Sci."},{"key":"23467_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy, J. & Allsop, D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol. Sci. 12, 383\u2013388 (1991).","journal-title":"Trends Pharmacol. Sci."},{"key":"23467_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"J Hardy","year":"1992","unstructured":"Hardy, J. & Higgins, G. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256, 184\u2013185 (1992).","journal-title":"Science"},{"issue":"3","key":"23467_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tins.2008.11.007","volume":"32","author":"TL Spires-Jones","year":"2009","unstructured":"Spires-Jones, T. L. et al. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci. 32 (3), 150\u2013159 (2009).","journal-title":"Trends Neurosci."},{"key":"23467_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13195-022-01055-y","volume":"14","author":"C Abdelnour","year":"2022","unstructured":"Abdelnour, C. et al. Perspectives and challenges in patient stratification in Alzheimer\u2019s disease. Alzheimers Res. Ther. 14, 112 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"23467_CR14","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/biomedicines11051398","volume":"11","author":"Y Ratan","year":"2023","unstructured":"Ratan, Y. et al. An insight into cellular and molecular mechanisms underlying the pathogenesis of neurodegeneration in Alzheimer\u2019s disease. Biomedicines 11, 1398 (2023).","journal-title":"Biomedicines"},{"key":"23467_CR15","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.arr.2024.102481","volume":"101","author":"PT Kamatham","year":"2024","unstructured":"Kamatham, P. T. et al. Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: breaking the memory barrier. Ageing Res. Rev. 101, 102481 (2024).","journal-title":"Ageing Res. Rev."},{"key":"23467_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Sig Transduct. Target. Ther. 9, 211 (2024).","journal-title":"Sig Transduct. Target. Ther."},{"key":"23467_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3892\/mco.2013.172","volume":".1","author":"I Jov\u010devska","year":"2013","unstructured":"Jov\u010devska, I. et al. Glioma and glioblastoma - how much do we (not) know? Mol. Clin. Oncol. .1, 935\u2013941 (2013).","journal-title":"Mol. Clin. Oncol."},{"key":"23467_CR18","doi-asserted-by":"publisher","first-page":"1549186","DOI":"10.3389\/fchem.2025.1549186","volume":"13","author":"S Pradeep","year":"2025","unstructured":"Pradeep, S. et al. Exploring shared therapeutic targets for Alzheimer\u2019s disease and glioblastoma using network Pharmacology and protein-protein interaction approach. Front. Chem. 13, 1549186 (2025).","journal-title":"Front. Chem."},{"issue":"3","key":"23467_CR19","doi-asserted-by":"publisher","first-page":"e14066","DOI":"10.1111\/acel.14066","volume":"23","author":"AP Ainslie","year":"2024","unstructured":"Ainslie, A. P. et al. Glioblastoma is associated with extensive accelerated brain ageing. Agging Cell. 23 (3), e14066 (2024).","journal-title":"Agging Cell."},{"key":"23467_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijms25010016","volume":"25","author":"J Shi","year":"2024","unstructured":"Shi, J. & Huang, S. Comparative insight into microglia\/macrophages-associated pathways in glioblastoma and Alzheimer\u2019s disease. Int. J. Mol. Sci. 25, 16 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"23467_CR21","doi-asserted-by":"publisher","first-page":"21535","DOI":"10.1038\/s41598-025-08000-7","volume":"15","author":"T Liu","year":"2025","unstructured":"Liu, T. et al. Potential role of TNFRSF12A in linking glioblastoma and Alzheimer\u2019s disease via shared tumour suppressor pathways. Sci. Rep. 15, 21535 (2025).","journal-title":"Sci. Rep."},{"key":"23467_CR22","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1038\/s41598-017-04400-6","volume":"7","author":"J S\u00e1nchez-Valle","year":"2017","unstructured":"S\u00e1nchez-Valle, J. et al. A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer\u2019s disease, glioblastoma and lung cancer. Sci. Rep. 7, 4474 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"23467_CR23","doi-asserted-by":"publisher","first-page":"vdae118","DOI":"10.1093\/noajnl\/vdae118","volume":"6","author":"L Greutter","year":"2024","unstructured":"Greutter, L. et al. Frequent Alzheimer\u2019s disease neuropathological change in patients with glioblastoma. Neuro-Oncology Adv. 6 (1), vdae118 (2024).","journal-title":"Neuro-Oncology Adv."},{"issue":"2","key":"23467_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ejmech.2008.01.031","volume":"44","author":"G Liang","year":"2009","unstructured":"Liang, G. et al. Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues. Eur. J. Med. Chem. 44 (2), 915\u2013919 (2009).","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"23467_CR25","first-page":"472","volume":"11","author":"MK Oglah","year":"2020","unstructured":"Oglah, M. K. et al. Curcumin and its derivatives: A review of their biological activities. Sys Rev. Pharm. 11 (3), 472\u2013481 (2020).","journal-title":"Sys Rev. Pharm."},{"key":"23467_CR26","first-page":"259","volume":"576","author":"RM Claramunt","year":"2016","unstructured":"Claramunt, R. M. et al. Curcumin derived pyrazoles and related compounds. Afinidad 576, 259\u2013268 (2016).","journal-title":"Afinidad"},{"key":"23467_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/cbdd.13076","volume":"91","author":"M Ahmed","year":"2018","unstructured":"Ahmed, M. et al. Screening of curcumin-derived isoxazole, pyrazoles, and pyrimidines for their anti-inflammatory, antinociceptive, and cyclooxygenase-2 Inhibition. Chem. Biol. Drug Des. 91, 338\u2013343 (2018).","journal-title":"Chem. Biol. Drug Des."},{"key":"23467_CR28","doi-asserted-by":"crossref","unstructured":"Chainoglou, E. & Hadjipavlou-Litina, D. Curcumin in health and diseases: Alzheimer\u2019s disease and curcumin analogues, derivatives, and hybrids. Int. J. Mol. Sci. 21, 1975 (2020).","DOI":"10.3390\/ijms21061975"},{"key":"23467_CR29","doi-asserted-by":"publisher","first-page":"100935","DOI":"10.1016\/j.rechem.2023.100935","volume":"5","author":"E Kabir","year":"2023","unstructured":"Kabir, E., Noyon, K. & Md., Hossain, A. Synthesis, biological and medicinal impacts of metallodrugs: A study. Results Chem. 5, 100935 (2023).","journal-title":"Results Chem."},{"issue":"8","key":"23467_CR30","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1021\/cr400460s","volume":"114","author":"K Dralle Mjos","year":"2014","unstructured":"Dralle Mjos, K. & Orvig, C. Metallodrugs in medicinal inorganic chemistry. Chem. Rev. 114 (8), 4540\u20134563 (2014).","journal-title":"Chem. Rev."},{"key":"23467_CR31","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3390\/pharmaceutics15082044","volume":"15","author":"C Ornelas","year":"2023","unstructured":"Ornelas, C. & Astruc, D. Ferrocene-Based Drugs, delivery nanomaterials and Fenton mechanism: state of the art, recent developments and prospects. Pharmaceutics 15, 2044 (2023).","journal-title":"Pharmaceutics"},{"key":"23467_CR32","doi-asserted-by":"crossref","unstructured":"Shoukat, H. & Altaf, A. A. A. Badshah. Advances in Metallodrugs: Preparation and Applications in Medicinal Chemistry (Eds. ul-Islam, S.,  Hashmi, A. A.,  Khan, S. A.). 115\u2013136  (Scrivener Publishing LLC, 2020).","DOI":"10.1002\/9781119640868.ch4"},{"key":"23467_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/inorganics10120226","volume":"10","author":"LV Snegur","year":"2022","unstructured":"Snegur, L. V. Modern trends in bio-organometallic ferrocene chemistry. Inorganics 10, 226 (2022).","journal-title":"Inorganics"},{"key":"23467_CR34","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1039\/D4QI01854K","volume":"11","author":"S La Manna","year":"2024","unstructured":"La Manna, S. et al. Enhancers of amyloid aggregation: novel ferrocene-based compounds selective toward amyloid models. Inorg. Chem. Front. 11, 6577\u20136587 (2024).","journal-title":"Inorg. Chem. Front."},{"key":"23467_CR35","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1039\/D0TB00144A","volume":"8","author":"P Yao","year":"2020","unstructured":"Yao, P. et al. Ferrocene-modified peptides as inhibitors against insulin amyloid aggregation based on molecular simulation. J. Mater. Chem. B. 8, 3076\u20133086 (2020).","journal-title":"J. Mater. Chem. B"},{"issue":"2","key":"23467_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ab.2012.11.025","volume":"434","author":"L Zhang","year":"2013","unstructured":"Zhang, L. et al. Kinetic studies of inhibition of the A\u03b2(1\u201342) aggregation using a ferrocene-tagged \u03b2-sheet breaker peptide. Anal. Biochem. 434 (2), 292\u2013299 (2013).","journal-title":"Anal. Biochem."},{"key":"23467_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/cphc.201100728","volume":"13","author":"S Beheshti","year":"2012","unstructured":"Beheshti, S., Martic, S. & Kraatz, H. B. Electrochemical signal-on reporter for amyloid aggregates. ChemPhysChem 13, 542\u2013548 (2012).","journal-title":"ChemPhysChem"},{"issue":"4","key":"23467_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2478\/acph-2024-0033","volume":"74","author":"G Poje","year":"2025","unstructured":"Poje, G. et al. Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids. Acta Pharm. 74 (4), 595\u2013612 (2025).","journal-title":"Acta Pharm."},{"key":"23467_CR39","doi-asserted-by":"publisher","first-page":"10404","DOI":"10.3390\/ijms221910404","volume":"22","author":"A Vessi\u00e8res","year":"2021","unstructured":"Vessi\u00e8res, A. et al. Heterogeneity of response to iron-based metallodrugs in glioblastoma is associated with differences in chemical structures and driven by FAS expression dynamics and transcriptomic subtypes. Int. J. Mol. Sci. 22, 10404 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"23467_CR40","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.3390\/molecules24193604","volume":"24","author":"S Peter","year":"2019","unstructured":"Peter, S. & Aderibigbe, B. A. Ferrocene-based compounds with antimalaria\/anticancer activity. Molecules 24, 3604 (2019).","journal-title":"Molecules"},{"key":"23467_CR41","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.nano.2014.05.002","volume":"10","author":"A-L Lain\u00e9","year":"2014","unstructured":"Lain\u00e9, A-L. et al. Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules. Nanomed. : Nanotechnol Biol. Med. 10, 1667\u20131677 (2014).","journal-title":"Nanomed. : Nanotechnol Biol. Med."},{"key":"23467_CR42","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1016\/j.ejmech.2011.05.043","volume":"46","author":"AC de Oliveira","year":"2011","unstructured":"de Oliveira, A. C. et al. Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: cancer cell growth inhibition, ROS production and hemolytic activity. Eur. J. Med. Chem. 46, 3778\u20133787 (2011).","journal-title":"Eur. J. Med. Chem."},{"key":"23467_CR43","doi-asserted-by":"publisher","first-page":"e7753","DOI":"10.1002\/aoc.7753","volume":"39","author":"V Kova\u010d","year":"2025","unstructured":"Kova\u010d, V. et al. Novel ferrocene-containing pyrazole analogs of curcumin: Synthesis, characterization, antioxidant activity, cyclic voltammetry, and in vitro biological evaluation. Appl. Organometal Chem. 39, e7753 (2025).","journal-title":"Appl. Organometal Chem."},{"key":"23467_CR44","doi-asserted-by":"crossref","unstructured":"Edison, A. S. & Schroeder, F. C.  Comprehensive Natural Products II, Chemistry and Biology (Eds. Mander, L., Liu, H.-W. ). Vol.  9. 169\u2013196 (Elsevier, 2009).","DOI":"10.1016\/B978-008045382-8.00196-9"},{"issue":"3","key":"23467_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbapap.2018.10.002","volume":"1867","author":"K Siposova","year":"2019","unstructured":"Siposova, K. et al. Inhibition of amyloid fibril formation and disassembly of pre-formed fibrils by natural polyphenol Rottlerin. BBA - Proteins Proteom. 1867 (3), 259\u2013274 (2019).","journal-title":"BBA - Proteins Proteom."},{"key":"23467_CR46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/pro.5560020312","volume":"2","author":"H LeVine","year":"1993","unstructured":"LeVine 3rd, H.  Thioflavine T interaction with synthetic alzheimer\u2019s disease beta-amyloid peptides: detection of amyloid aggregation in solution. Prot. Sci. 2, 404\u2013410 (1993).","journal-title":"Prot. Sci."},{"key":"23467_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jsb.2007.06.004","volume":"159","author":"M Groenning","year":"2007","unstructured":"Groenning, M. et al. Binding mode of thioflavin T in insulin amyloid fibrils. J. Struct. Biol. 159, 483\u2013497 (2007).","journal-title":"J. Struct. Biol."},{"key":"23467_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jlumin.2014.10.042","volume":"159","author":"K Vus","year":"2015","unstructured":"Vus, K. et al. Thioflavin T derivatives for the characterization of insulin and lysozyme amyloid fibrils in vitro: fluorescence and quantum-chemical studies. J. Lumin. 159, 284\u2013293 (2015).","journal-title":"J. Lumin."},{"issue":"1","key":"23467_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/19336896.2020.1720487","volume":"14","author":"MI Sulatsky","year":"2020","unstructured":"Sulatsky, M. I. et al. Effect of the fluorescent probes ThT and ANS on the mature amyloid fibrils. Prion 14 (1), 67\u201375 (2020).","journal-title":"Prion"},{"key":"23467_CR50","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1747-0285.2007.00557.x","volume":"70","author":"AA Reinke","year":"2007","unstructured":"Reinke, A. A. & Gestwicki, J. E. Structure\u2013activity relationships of amyloid Beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem. Biol. Drug Des. 70, 206\u2013215 (2007).","journal-title":"Chem. Biol. Drug Des."},{"key":"23467_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1021\/acs.jcim.9b00561","volume":"60","author":"JM Jakubowski","year":"2020","unstructured":"Jakubowski, J. M. et al. Interactions between curcumin derivatives and amyloid\u2013\u03b2 fibrils: insights from molecular dynamics simulations. J. Chem. Inf. Model. 60, 289\u2013305 (2020).","journal-title":"J. Chem. Inf. Model."},{"issue":"14","key":"23467_CR52","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1016\/j.bmc.2018.07.027","volume":"26","author":"G Orteca","year":"2018","unstructured":"Orteca, G. et al. Curcumin derivatives and A\u03b2-fibrillar aggregates: an interactions\u2019 study for diagnostic\/therapeutic purposes in neurodegenerative diseases. Bioorg. Med. Chem. 26 (14), 4288\u20134300 (2018).","journal-title":"Bioorg. Med. Chem."},{"key":"23467_CR53","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1002\/asia.202100965","volume":"16","author":"S Nath","year":"2021","unstructured":"Nath, S. et al. Hydroxy-porphyrin as an effective, endogenous molecular clamp during early stages of amyloid fibrillization. Chem. Asian J. 16, 3931\u20133936 (2021).","journal-title":"Chem. Asian J."},{"key":"23467_CR54","doi-asserted-by":"publisher","first-page":"126331","DOI":"10.1016\/j.ijbiomac.2023.126331","volume":"251","author":"K Siposova","year":"2023","unstructured":"Siposova, K. et al. Biocompatible zeolite-dye composites with anti-amyloidogenic properties. Int. J. Biol. Macromol. 251, 126331 (2023).","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"23467_CR55","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/cbdd.12847","volume":"89","author":"E Ferrari","year":"2017","unstructured":"Ferrari, E. et al. Vitro study on potential pharmacological activity of curcumin analogues and their copper complexes. Chem. Biol. Drug Des. 89 (3), 411\u2013419 (2017).","journal-title":"Chem. Biol. Drug Des."},{"key":"23467_CR56","doi-asserted-by":"publisher","first-page":"112539","DOI":"10.1016\/j.jphotobiol.2022.112539","volume":"234","author":"V Pevna","year":"2022","unstructured":"Pevna, V. et al. Photobiomodulation and photodynamic therapy-induced switching of autophagy and apoptosis in human dermal fibroblasts. J. Photochem. Photobiol B. 234, 112539 (2022).","journal-title":"J. Photochem. Photobiol B"},{"key":"23467_CR57","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3390\/biomedicines9111703","volume":"9","author":"V Pevna","year":"2021","unstructured":"Pevna, V., Wagni\u00e8res, G. & Huntosova, V. Autophagy and apoptosis induced in U87 MG glioblastoma cells by hypericin-mediated photodynamic therapy can be photobiomodulated with 808 nm light. Biomedicines 9, 1703 (2021).","journal-title":"Biomedicines"},{"key":"23467_CR58","doi-asserted-by":"crossref","unstructured":"Schleinkofer, K., Wang, T. & Wade, R. C. Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine. 1149\u20131153 (Springer,  2006).","DOI":"10.1007\/3-540-29623-9_3820"},{"issue":"8","key":"23467_CR59","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.3390\/molecules27082537","volume":"27","author":"N Georgiou","year":"2022","unstructured":"Georgiou, N. et al. Conformational properties of new thiosemicarbazone and thiocarbohydrazone derivatives and their possible targets. Molecules 27 (8), 2537 (2022).","journal-title":"Molecules"},{"key":"23467_CR60","doi-asserted-by":"crossref","unstructured":"Paravastu, A. K. et al. Molecular structural basis for polymorphism in Alzheimer\u2019s \u03b2-amyloid fibrils. Proc. Natl. Acad. Sci. 105(47), 18349\u201318354 (2008).","DOI":"10.1073\/pnas.0806270105"},{"issue":"1","key":"23467_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-1-15","volume":"1","author":"Z Bikadi","year":"2009","unstructured":"Bikadi, Z. & Hazai, E. Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J. Cheminform. 1 (1), 1\u201316 (2009).","journal-title":"J. Cheminform"},{"issue":"P2","key":"23467_CR62","doi-asserted-by":"publisher","first-page":"136430","DOI":"10.1016\/j.molstruc.2023.136430","volume":"1294","author":"G Leonis","year":"2023","unstructured":"Leonis, G. et al. Computational and spectroscopic analysis of the Quercetin encapsulation in (2HP-\u03b2-CD)2 and (2,6Me-\u03b2-CD)2 complexes. J. Mol. Struct. 1294 (P2), 136430 (2023).","journal-title":"J. Mol. Struct."},{"key":"23467_CR63","unstructured":"Frisch, M. J. et al.  Gaussian 16, Revision B.01. (Gaussian 09; 2016)."},{"key":"23467_CR64","doi-asserted-by":"publisher","first-page":"955282","DOI":"10.3389\/fmolb.2022.955282","volume":"9","author":"K Siposova","year":"2022","unstructured":"Siposova, K. et al. The intriguing dose-dependent effect of selected amphiphilic compounds on insulin amyloid aggregation: focus on a cholesterol-based detergent, Chobimalt. Front. Mol. Biosci. 9, 955282 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"23467_CR65","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1021\/acs.jpcb.5b00006","volume":"119","author":"MH Viet","year":"2015","unstructured":"Viet, M. H. et al. In Silico and in vitro study of binding affinity of tripeptides to amyloid \u03b2 fibrils: implications for Alzheimer\u2019s disease. J. Phys. Chem. B. 119, 5145\u20135155 (2015).","journal-title":"J. Phys. Chem. B"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23467-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23467-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23467-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:40:08Z","timestamp":1763448008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23467-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23467"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23467-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39867"}}